Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-043844

OPKO HEALTH, INC. · OPK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Md Et Al Frost
Officer — CEO & Chairman · Director · 10% Owner
Period of report
Jul 24, 2018
Accepted (ET)
Jul 25, 2018 · 6:52 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000944809

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jul 24, 2018P500$5.39A4,078,370ISee Footnote
Common StockF1Jul 24, 2018P400$5.395A4,078,770ISee Footnote
Common StockF1Jul 24, 2018P100$5.3975A4,078,870ISee Footnote
Common StockF1Jul 24, 2018P9,000$5.40A4,087,870ISee Footnote
Common StockF1Jul 24, 2018P10,000$5.51A4,097,870ISee Footnote
Common StockF1Jul 24, 2018P400$5.52A4,098,270ISee Footnote
Common StockF1Jul 24, 2018P1,500$5.53A4,099,770ISee Footnote
Common StockF1Jul 24, 2018P2,000$5.54A4,101,770ISee Footnote
Common StockF1Jul 24, 2018P2,150$5.575A4,103,920ISee Footnote
Common StockF1Jul 24, 2018P500$5.5775A4,104,420ISee Footnote
Common StockF1Jul 24, 2018P3,450$5.58A4,107,870ISee Footnote
Common StockF1Jul 24, 2018P100$5.64A4,107,970ISee Footnote
Common StockF1Jul 24, 2018P1,100$5.645A4,109,070ISee Footnote
Common StockF1Jul 24, 2018P1,400$5.646A4,110,470ISee Footnote
Common StockF1Jul 24, 2018P200$5.6475A4,110,670ISee Footnote
Common StockF1Jul 24, 2018P2,200$5.65A4,112,870ISee Footnote
Common StockF1Jul 24, 2018P1,628$5.665A4,114,498ISee Footnote
Common StockF1Jul 24, 2018P300$5.6675A4,114,798ISee Footnote
Common StockF1Jul 24, 2018P3,072$5.67A4,117,870ISee Footnote
Common StockF1Jul 24, 2018P1,600$5.715A4,119,470ISee Footnote
Common StockF1Jul 24, 2018P1,200$5.7175A4,120,670ISee Footnote
Common StockF1Jul 24, 2018P2,200$5.72A4,122,870ISee Footnote
Common StockF1Jul 24, 2018P10,000$5.79A4,132,870IFrost NVSee Footnote
Common Stockholding———3,068,951D
Common StockF2holding———164,234,443ISee Footnote
Common StockF3holding———20,091,062ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses